ARROWHEAD PHARMACEUTICALS, INC. Annual Operating Lease, Payments in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Arrowhead Pharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2018 to 2023.
  • Arrowhead Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending June 30, 2024 was $3.2M, a 70% increase year-over-year.
  • Arrowhead Pharmaceuticals, Inc. Operating Lease, Payments for the twelve months ending June 30, 2024 was $8.22M.
  • Arrowhead Pharmaceuticals, Inc. annual Operating Lease, Payments for 2023 was $5.2M, a 15.6% increase from 2022.
  • Arrowhead Pharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $4.5M, a 45.2% increase from 2021.
  • Arrowhead Pharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $3.1M, a 72.2% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $5.2M +$704K +15.6% Oct 1, 2022 Sep 30, 2023 10-K 2023-11-29
2022 $4.5M +$1.4M +45.2% Oct 1, 2021 Sep 30, 2022 10-K 2023-11-29
2021 $3.1M +$1.3M +72.2% Oct 1, 2020 Sep 30, 2021 10-K 2023-11-29
2020 $1.8M +$500K +38.5% Oct 1, 2019 Sep 30, 2020 10-K 2021-11-22
2019 $1.3M $0 0% Oct 1, 2018 Sep 30, 2019 10-K 2021-11-22
2018 $1.3M Oct 1, 2017 Sep 30, 2018 10-K 2020-11-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.